  The Advanced Breast Cancer Fourth Consensus ( ABC4) on diagnosis and treatment of advanced breast cancer ( ABC) again took place in Lisbon , on November 2-4 , 2017 , and was chaired by Fatima Cardoso , MD , PhD. This year 's contents focused very much on new developments in the treatment of ABC. For example , the significance of inhibition of cyclin-dependent kinases 4 and 6 ( CDK4/6) in hormone receptor ( HR)- positive ABC , of dual antibody blockade in human epidermal growth factor receptor 2 ( HER2)- positive ABC , and of poly ( ADP-ribose) polymerase ( PARP) inhibition in triple-negative ABC , as well as the potential therapeutic consequences , were discussed. Other key issues were